EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of COVID-19 pandemic on diagnosis and treatment access of patients with viral hepatitis in Turkey

Fatma Eser, Rahmet Güner, Yunus Gürbüz, Meral Akdoğan, Zeynep Bilgiç, Nesibe Korkmaz, Derya Arı, Gamze Şanlıdağ, Şengül Kesim Uçar, Tolga Düzenli, Tansu Yamazhan

The Journal of Infection in Developing Countries · 2023

DOI: 10.3855/jidc.17585 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2023. Verfasst von Fatma Eser und 10 weiteren Autor:innen. Beteiligte Einrichtung: Ankara Yıldırım Beyazıt University, Ankara City Hospital, Infectious Disease and Clinical Microbiology, Ankara, Turkey. Hauptthemen laut MEDLINE: COVID-19, Hepatitis B, Hepatitis C. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

We aimed to evaluate access to diagnosis, treatment and follow-up in patients with viral hepatitis during the COVID-19 pandemic. Methodology: Patients who started treatment for hepatitis B and hepatitis C were included in the study and analyzed in two periods: before-pandemic and during-pandemic. Indication for treatment and frequency of laboratory follow-up was obtained from hospital records. A telephone survey was administered to evaluate treatment access and compliance.

Results

Four centers with 258 patients were included in the study. Of these 161 (62.4%) were male, median age was 50 years. The number of patients, admitted to outpatient clinics was 134647 in the before-pandemic period and 106548 in the during-pandemic period. Number of patients who started treatment for hepatitis B were significantly high during-pandemic period compared with before-pandemic (78 (0.07%); 73 (0.05%) respectively; p = 0.04). The number who received treatment for hepatitis C was similar in both periods: 43 (0.04%); 64 (0.05%), respectively (p = 0.25). Prophylactic treatment for hepatitis B, due to immunosuppressive agents was significantly higher in during-pandemic period (p = 0.001). In the laboratory follow-ups at 4th, 12th and 24th weeks of treatment, worse adherence was detected in during-pandemic (for all p < 0.05). Access to treatment and compliance of all patients was over 90% and did not differ in the two periods.

Conclusions

During-pandemic, hepatitis patients' access to diagnosis, treatment initiation and follow-up had worsened in Turkey. The health policy implemented during the pandemic had a positive impact on patients' access to and compliance to treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Hepatitis BHepatitis CHumansMaleMiddle AgedFemalePandemicsTurkeyHepacivirusCOVID-19 Testing

Stichwörter der Autor:innen

COVID-19Hepatitis BHepatitis Caccesstreatment

Autor:innen und Institutionen

  • Ankara Yıldırım Beyazıt University, Ankara City Hospital, Infectious Disease and Clinical Microbiology, Ankara, Turkey.
  • University of Health Sciences, Ankara Dışkapı Yıldırım Beyazıt Training and Research Hospital, Infectious Disease and Clinical Microbiology, Ankara, Turkey.
  • University of Health Sciences, Ankara City Hospital, Department of Gastroenterology, Ankara, Turkey.
  • Tunceli Public Hospital, Infectious Disease and Clinical Microbiology, Tunceli, Turkey.
  • Ankara Dışkapı Yıldırım Beyazıt Training and Research Hospital, Infectious Disease and Clinical Microbiology, Ankara, Turkey.
  • Ankara City Hospital, Department of Gastroenterology, Ankara, Turkey.

Zitieren

APA

Eser, F., Güner, R., Gürbüz, Y., Akdoğan, M., Bilgiç, Z., Korkmaz, N., Arı, D., Şanlıdağ, G., Kesim Uçar, Ş., Düzenli, T., & Yamazhan, T. (2023). Impact of COVID-19 pandemic on diagnosis and treatment access of patients with viral hepatitis in Turkey. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.17585

Vancouver

Eser F, Güner R, Gürbüz Y, Akdoğan M, Bilgiç Z, Korkmaz N, et al. Impact of COVID-19 pandemic on diagnosis and treatment access of patients with viral hepatitis in Turkey. The Journal of Infection in Developing Countries. 2023. doi:10.3855/jidc.17585

BibTeX
@article{Eser2023,
  author = {Eser, Fatma and Güner, Rahmet and Gürbüz, Yunus and Akdoğan, Meral and Bilgiç, Zeynep and Korkmaz, Nesibe and Arı, Derya and Şanlıdağ, Gamze and Kesim Uçar, Şengül and Düzenli, Tolga and Yamazhan, Tansu},
  title = {Impact of COVID-19 pandemic on diagnosis and treatment access of patients with viral hepatitis in Turkey},
  journal = {The Journal of Infection in Developing Countries},
  year = {2023},
  doi = {10.3855/jidc.17585}
}
Kostenlos starten →